CARCINOMA, NEUROENDOCRINE
Clinical trials for CARCINOMA, NEUROENDOCRINE explained in plain language.
Never miss a new study
Get alerted when new CARCINOMA, NEUROENDOCRINE trials appear
Sign up with your email to follow new studies for CARCINOMA, NEUROENDOCRINE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First patients sought for groundbreaking trial targeting rare, aggressive cancers
Disease control Recruiting nowThis is the first-ever study in people for a new drug called ADCT-701, designed for adults with rare and hard-to-treat cancers like neuroendocrine tumors and malignant peripheral nerve sheath tumors. The main goal is to find the safest and most effective dose by giving the drug t…
Matched conditions: CARCINOMA, NEUROENDOCRINE
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Your genes could dictate your cancer drug dose
Disease control Recruiting nowThis study is testing whether adjusting the dose of a cancer drug (belinostat) based on a patient's specific genetics can make treatment safer and more effective. It is for adults with aggressive neuroendocrine cancers. Participants receive a combination of three drugs, with the …
Matched conditions: CARCINOMA, NEUROENDOCRINE
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 17, 2026 13:09 UTC
-
New lab test aims to match cancer patients with the right drug faster
Knowledge-focused Recruiting nowThis study is testing a new laboratory method to see if it can predict which cancer treatments will work best for a patient. Researchers will take a sample of a patient's tumor cells from a fluid or tissue biopsy and test how the cells react to different drugs in the lab. The goa…
Matched conditions: CARCINOMA, NEUROENDOCRINE
Sponsor: Travera Inc • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:18 UTC
-
Landmark study tracks rare cancers for life to unlock treatment secrets
Knowledge-focused Recruiting nowThis study aims to learn more about rare neuroendocrine cancers by observing people who have them over their lifetime. Researchers will collect blood, saliva, and tumor samples from up to 300 participants to understand how these cancers progress and what treatments work best. The…
Matched conditions: CARCINOMA, NEUROENDOCRINE
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Mar 16, 2026 15:26 UTC